In this workshop, Irene González Barahona (Key Account Manager from East Coast – US and Canada) presents Cytognos Next Generation Flow solution for MM MRD assays which allows for a highly sensitive and effective detection of abnormal plasma cells at very low levels, provides information about sample quality (hemodilution) and bone marrow regeneration after therapy.
This workshop was first displayed at ICCS 2020. Watch this video to learn how you can improve the care of patients with Multiple Myeloma by using this complete flow approach.